UNSPSC 51183105: Gliflumide

This classification denotes an anti-diabetic agent with the molecular formula C25H29FN4O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) USE67B01YN, chemically known as benzeneacetamide, n-((1s)-1-(5-fluoro-2-methoxyphenyl)ethyl)-4-(((5-(2-methylpropyl)-2-pyrimidinyl)amino)sulfonyl)- but more generally known as gliflumide, which bears US NIH Compound Identifier 197722. European Medicines Agency schedules Gliflumide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07924MIG.

UNSPSC 51183105 Gliflumide is a Commodity code that covers the procurement of this specific oral antidiabetic agent by state and local public health and human services agencies. State and local governments purchase gliflumide as a pharmaceutical line item through their Medicaid programs, public health departments, state employee health plans, and corrections systems. The drug is typically acquired through competitive pharmaceutical procurement channels, often bundled with other diabetes management medications or procured as a standalone therapeutic agent when formulary requirements or patient population needs justify single-drug acquisition.

The recent-opportunities block provided contains no entries, indicating no posted state and local RFP, RFQ, IFB, or ITB solicitations under this code are currently visible in the source data. Without active solicitation records, geographic concentration and representative opportunities cannot be characterized from the source.